Purpose Ovarian cancer is a leading cause of gynecologic malignancy. As symptoms of ovarian cancer are nonspecific, only 20 % of ovarian cancers are diagnosed while they are still limited to the ovaries. Thus, early and accurate detection of disease is important for an improved prognosis. For the accurate and effective diagnosis of ovarian malignancy on 18
Ffluorodeoxyglucose ( 1 8 F-FDG) positron emission tomography/computed tomography (PET/CT), we analyzed several parameters, including visual assessment. Method A total of 51 peritoneal lesions in 19 patients who showed ovarian masses with diffuse peritoneal infiltration were enrolled. Twelve patients were confirmed to have ovarian malignancy and seven patients with benign disease by pathologic examination. All patients were examined by 18 F-FDG PET/CT, and an additional 2-h delayed 18 F-FDG PET/ CT was also performed for 15 patients with 42 peritoneal lesions. We measured semiquantitative parameters including maximum and mean standardized uptake values (SUVmax, SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) on a 1-h initial 18 F-FDG PET/CT image (Parameter 1 ) and on a 2-h delayed image (Parameter 2 ). Additionally, retention indices of each parameter were calculated, and each parameter among the malignant and benign lesions was compared by Mann-Whitney U test. We also assessed the visual characteristics of each peritoneal lesion, including metabolic extent, intensity, shape, heterogeneity, and total visual score. Associations between visual grades and malignancy were analyzed using linear by linear association methods. Moreover, a receiver operating characteristic (ROC) curve was analyzed to compare the effectiveness of significant parameters.
Result In a comparison between the malignant and benign groups in the analysis of 51 total peritoneal lesions, SUVmax 1 , SUVmean 1 , and TLG 1 showed significant differences. Also, in the analysis of 42 peritoneal lesions that underwent an additional 2-h 18 F-FDG PET/CT examination, SUVmax 1,2 , SUVmean 1,2 , TLG 2 , and the RI of TLG showed significant differences between the malignant and benign groups. MTV did not show significant differences in either the analysis of 51 peritoneal lesions or of 42 lesions. Regarding visual assessments, metabolic intensity, shape, heterogeneity, and total visual score showed an association with malignancy. In the ROC analysis, the AUC of the visual score was larger than the AUC of other parameters in both the analyses of 51 peritoneal lesions and of 42 lesions. Conclusion Although further study with a larger patient population is needed, the visual assessment of
Introduction
Ovarian cancer is the second most common gynecological cancer in Western women, and also in Korea, next to uterine cervical cancer [1, 2] . As the symptoms are nonspecific, only 20 % of ovarian cancers are diagnosed while they are still limited to the ovaries [3] . This is why ovarian cancer is the leading cause of death among gynecological cancers. Therefore, early detection and characterization are important and continuing challenges. Imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) have been proposed as adjunct methods to conventional transvaginal ultrasonography. However, despite having higher sensitivity and specificity than ultrasonography, a preoperative diagnosis using CT or MRI is often indeterminate [4, 5] . Recently, 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET)/CT has gained widespread acceptance in diagnosing and staging various cancers. Nevertheless, most studies using 18 F-FDG PET/CT in ovarian cancer patients have been limited to detecting recurrence or distant metastasis, and relatively few studies have demonstrated the effectiveness of 18 F-FDG PET/CT in detecting primary ovarian cancer [6, 7] . Moreover, although these studies suggest the high diagnostic value of 18 F-FDG PET/CT in detecting primary ovarian cancer, some pitfalls also exist. False-positive results, including those resulting from pelvic inflammatory disease, an ovarian cyst, and endometriosis, and false-negative results including those from borderline malignancies have been reported [6, 8, 9] .
Some parameters are used as diagnostic criteria for 18 F-FDG PET/CT to increase the accuracy of detecting malignancy. The most typical diagnostic criterion parameter is the maximum standardized uptake value (SUVmax). However, SUVmax has limitations, because it is also increased in benign conditions related to physiologic variations, degeneration, and infection or inflammation, as well as in malignant lesions [10] . One of the methods to overcome this problem is to use dualtime point PET imaging in the identification of malignant lesions. Various studies have reported the effectiveness of dual-time point PET imaging in different malignancies [11] [12] [13] [14] . They suggested the retention index (RI), the percentage change between the 1-h SUVmax and the 2-h SUVmax, as a diagnostic criterion. However, there are few studies on patients with ovarian cancers. Furthermore, from the view of cost-effectiveness, there is some inefficiency, as delayed 2-h 18 F-FDG-PET/CT requires additional costs and radiation exposure.
Recently, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) have become remarkable parameters as prognostic factors for various cancers [15] [16] [17] [18] . However, there are only a few studies using MTV or TLG in ovarian cancer patients; most of these studies used MTV and TLG as prognostic factors of recurrence rather than as diagnostic factors [19, 20] .
In practice, visual analysis is the most important factor when interpreting 18 F-FDG-PET/CT imaging. Miller et al. [21] suggested the visual scoring of 18 F-FDG PET as a prognostic factor in cervical cancer patients. They analyzed characteristics of the primary tumor by size, shape, and heterogeneity of 18 F-FDG uptake. However, to our knowledge, there are no reports regarding the visual assessment of 18 F-FDG-PET/CT imaging for ovarian cancer diagnosis.
The aim of our study was to find the optimal parameters for 18 F-FDG-PET/CT imaging to improve the diagnostic accuracy of ovarian cancers.
Methods

Patients
We retrospectively reviewed patients who underwent 18 F-FDG PET/CT for staging work up of ovarian masses with peritoneal infiltration that were identified on abdomen-pelvis CT or pelvic MRI from March 2009 to February 2011 at our hospital. All patients were examined by physical examination, pelvic ultrasonography, abdomen-pelvis CT, or pelvic MRI. Patients who had a history of other types of cancers or a previous treatment history of ovarian cancer were excluded. All patients underwent a gynecologic operation and the intraperitoneal lesions were pathologically confirmed. Total of 19 patients were selected for this study evaluation. 18 F-FDG PET/CT Image Acquisition 18 F-FDG PET/CT images were obtained on a PET/CT scanner (Gemini TF; Philips Medical Systems, Cleveland, OH). All patients fasted for at least 6 h and had serum glucose levels less than 140 mg/dL before scanning. Dual-time point PET/ CT images were obtained at 60 and 120 min. One hour and 2 h after an intravenous injection of 370-555 MBq 18 F-FDG according to the body weight, CT scans were obtained followed by PET scans for 1 min per bed. The PET unit has an axial field-of-view of 18 cm and a spatial resolution of 4.4 mm. A low-dose CT scan was obtained for attenuation correction and localization on a 16-slice multidetector helical CT unit using the following parameters: 120 kVp; 50 mA; 0.75-s rotation time; 0.75-mm slice collimation; 4-mm scan reconstruction, with a reconstruction index of 4 mm; 50-cm field of view, and 512×512 matrices. PET data were reconstructed iteratively using a three-dimensional row action maximum likelihood algorithm (RAMLA) with low-dose CT datasets used for attenuation correction. Maximum intensity projection (MIP), cross-sectional views, and fusion images were reviewed.
Image Interpretation and Quantitation
All images were interpreted and analyzed by two experienced nuclear medicine physicians on a dedicated workstation (Extended Brilliance Workspace 4.0 with a PET/CT viewer for automated image registration; Philips, Amsterdam, Netherlands). We used all available clinical information, including radiological examinations such as CT and MRI.
We defined each intraperitoneal lesion that showed relatively increased metabolism compared with the metabolisms of adjacent normal tissues. CT and MRI findings were also considered to select lesions. And the characteristics of each lesion, including ovarian lesions, were evaluated independently, as lesion-by-lesion analysis.
For the visual assessment, we evaluated each intraperitoneal lesion by using several parameters, including metabolic extent, shape, intensity, and heterogeneity (Table 1) . Metabolic extent was measured on background CT and was scored as 0 for less than 4 cm, 1 for 4-10 cm, and 2 for more than 10 cm. Shape was scored as 0 for spherical, 1 for mixed, and 2 for non-spherical. Metabolic intensity of each intraperitoneal lesion was scored based on a comparison with liver activity, as 0 for hypometabolism or isometabolism, 1 for mild hypermetabolism, 2 for moderate hypermetabolism, and 3 for intense hypermetabolism. Heterogeneity was scored as 0 for homogeneous, 1 for moderate, and 2 for marked, where moderate heterogeneity was approximately a 10-30 % count variation across the tumor and marked was a variation of more than 30 % [21] . Then, the scores of each parameter were summed for a "visual score." Thus, the visual score could range from a minimum of 0 to a maximum of 9. Discordant results were fully discussed and interpreted by consensus of the two physicians.
For a semi-quantitative analysis, we measured the standardized uptake values (SUVs) of intraperitoneal lesions by drawing a region of interest (ROI).
An ROI was placed over the area of maximum activity within the intraperitoneal lesions, and the SUVmax was obtained as the highest SUV of the pixels within the ROI.
Furthermore, we measured the MTV of each ROI. We delineated a volume of interest (VOI) over the intraperitoneal lesions and the SUV-based automated contouring software calculated the MTV. Fifty percent of the local maximum intensity was used as the threshold intensity value, and this was deemed reasonable from phantom studies [17, 22] . The program also analyzed the mean of the SUV (SUVmean) as well as the TLG of each VOI, which was calculated by multiplying MTV by SUVmean. All semi-quantitative parameters were measured on 1-h and 2-h 
Statistical Analysis
Statistical calculations were performed using SPSS version 18.0 (SPSS, Chicago, IL). Semi-quantitative parameters including SUVmax, SUVmean, MTV, and TLG on both the 1-h and 2-h images and the RI of each parameter were compared between the malignant and benign groups by using a MannWhitney U test. Visual parameters including metabolic extent, shape, intensity, heterogeneity, and total visual score were compared between the two groups using a linear by linear association for trend test. A value of P<0.05 was considered statistically significant.
Results
Patients' Characteristics
A total of 19 patients were enrolled and reviewed. The mean age of the patients with malignancy was 59.6±10.0 years and that of patients with benign lesions was 42.7±11.9 years. All 19 patients showed diffuse peritoneal infiltration on preoperative CT or MRI. The preoperative CT or MRI findings of all patients suggested malignancy as the first differential diagnosis, but other conditions could not be excluded. Twelve patients were pathologically diagnosed with primary ovarian cancers: eight serous adenocarcinomas, three mucinous adenocarcinomas, and one endometrioid carcinoma. We considered all intraperitoneal lesions in patients with malignancy as All parameters were measured on 1-h 18 F-FDG PET/CT image malignant lesions, while only some were pathologically confirmed. The remaining seven patents had benign lesions: two due to tuberculosis, one due to pelvic inflammatory disease (PID), and four due to endometriosis. In the same way, we regarded all intraperitoneal lesions from patients with benign lesions as non-cancerous. A total of 51 intraperitoneal lesions from 19 patients were detected. Thirty-two lesions were identified in patients with malignancy and 19 lesions in non-cancerous patients. The mean numbers of identified intraperitoneal lesions from patients with malignancy was 2.7 (±1.2) and from patients with benign lesions was 2.7 (±1.6). They were not significantly different (P=0.761). The characteristics of the enrolled patients and intraperitoneal lesions are summarized in Table 2 . 18 
F-FDG PET/CT Findings and Statistical Results
Because four patients did not undergo an additional delayed 18 F-FDG PET/CT examination, we analyzed the delayed parameters and RI of each parameter for only 15 patients with 42 intraperitoneal lesions. On the other hand, the parameters of 1-h imaging including SUVmax 1 , SUVmean 1 , MTV 1 , TLG 1 , and all visual parameters were analyzed in a total of 51 intraperitoneal lesions. All nine intraperitoneal lesions from the four patients who were not examined by delayed In the visual assessment, we analyzed whether higher scores had a tendency to predict malignancy by using a trend test. In the visual assessment of metabolic extent, extended hypermetabolism of intraperitoneal lesions had no statistically significant tendency to predict malignancy (P=0.372). However, non-spherical hypermetabolic lesions tended to be more malignant than spherical types (P<0.001). Moreover, intense hypermetabolic lesions (P<0.001) and heterogeneous hypermetabolic lesions (P=0.004) had tendencies to predict malignancy. Regarding total visual scoring, a high visual score had a statistically significant tendency to predict malignancy (P<0.001). The mean score of malignant lesions was 5.63 (95 % CI, 4.94-6.31), while that of benign lesions was 2.26 (95 % CI, 1.50-3.03). 18 F-FDG PET/CT images of some patients are shown in Fig. 1 and these results are summarized in Table 3 .
To compare the usefulness of each parameter that showed a statistically significant diagnostic value for malignancy, we evaluated a receiver operating characteristic (ROC) curve (Fig. 2) . The area under the curve (AUC) of SUVmax 1 was 0.898 (P<0.001); that of SUVmean 1 was 0.856 (P<0.001); that of TLG 1 was 0.678 (P=0.035); and that of visual score was 0.905 (P<0.001). From these results, visual score had the highest value in diagnosing malignancy, and the estimated optimal cut-off value was 4.5 (Table 4) . Table 3 . By the Mann-Whitney U test, there were statistically significant differences between the malignant and benign groups in SUVmax 1 , SUVmax 2 , SUVmean 1 , SUVmean 2 , TLG 2 , and the RI of TLG. MTV 1 , MTV 2 , TLG 1 , and the RI of other parameters did not show significant differences.
By visual assessment, there was a significant association between malignancy and high metabolic shape scores (P < 0.001), intensity (P < 0.001), and heterogeneity Table 5 .
As shown in Fig. 3 , visual score had the highest AUC at 0.911 (P<0.001) in the ROC curve analysis of significant parameters. The AUC of SUVmax 1 was 0.900 (P<0.001); that of SUVmax 2 was 0.896 (P<0.001); that of SUV mean 1 was 0.852 (P < 0.001); that of SUVmean 2 was 0.862 (P<0.001); that of TLG 2 was 0.698 (P=0.029); and that of the RI of TLG was 0.700 (P=0.027). The estimated optimal cut-off value for visual score was 4.50, and the same as in the previous analysis. These results are shown in Table 6 . 
Discussion
Compared with other gynecologic malignancies, ovarian cancer is often a fatal disease resulting from late diagnosis. Actually, in our studies, all of the ovarian malignancy patients had advanced disease with peritoneal carcinomatosis. It is hard to detect ovarian malignancy earlier, because its symptoms are not specific. Therefore, it is important to distinguish malignancy from benign disease during the initial work-up process instead of during early patient visits. After the introduction of combined 18 F-FDG PET/CT in 2000 [23] , 18 F-FDG PET/CT has been widely used as an imaging modality, and especially in cancer diagnosis, staging, and post-therapeutic response monitoring [24] . However, despite the previously reported high sensitivity of 18 F-FDG PET/ CT, false-positive findings mimicking malignancies also exist. They include not only physiologic activity, muscle activity, and urine activity, but infection and inflammation as well [10] . Especially in the pelvic cavity, the physiologic ovarian and endometrial activities resulting from the menstrual cycle can mimic malignancy. Lerman et al. [25] reported physiologic ovarian FDG uptakes in 21 premenopausal women out of 112 with an SUVmean of 5.7±1.5. Therefore, several parameters have been previously introduced to increase the specificity of 18 F-FDG PET/CT. In our study of 51 peritoneal lesions, there were significant differences in SUVmax 1 , SUVmean 1 , and TLG 1 between malignant and benign lesions. SUVmax is the most commonly used parameter in practice. Generally, malignant lesions are known to have a much higher SUVmax than benign lesions. Our results also showed that higher median SUVmax values were observed in malignant lesions than in benign lesions. However, the SUVmax of two tuberculous lesions were 10.3 and 7.7. Therefore, there is an obvious limitation in predicting malignancy with SUVmax alone. Despite SUVmean values of malignant lesions that were not high enough, there were significant differences between the malignant and benign groups. In general, SUVmean is known to have some limitations as a diagnostic parameter. Firstly, it is difficult to set the cut-off value, and secondly, there is variability between observers when drawing the ROI [26] . However, in our study, we used a VOI automatically drawn by a computer program so that interobserver variation would be minimal. Interestingly, TLG 1 showed a significant difference between the two cancers [15, 17, [27] [28] [29] . In ovarian cancer, Chung et al. [25] reported that MTV and TLG had a significant association with recurrence [16] . As in our study, TLG showed a significant difference between the two groups, and we consider that TLG has potential as a diagnostic parameter. Dual-time point 18 F-FDG PET was suggested to distinguish malignancy from benign lesions in 1999 [30] . Zhuang et al. [13] reported that the average SUV of malignant lesions increased on delayed PET imaging, while the average SUV of benign lesions decreased or remained stable, and several studies have reported the usefulness of dual-time point 18 F-FDG PET or PET/CT as diagnostic modalities. Also in our previous report, we evaluated the effectiveness of dual-phase 18 F-FDG PET/CT for differentiating benign ovarian lesions from malignant lesions [31] . However, a recent report by Cheng et al. [32] suggested that it is difficult to distinguish active inflammation and infection from malignancy. They reviewed multiple studies and indicated that active inflammatory and infectious lesions may have higher FDG activity on delayed PET imaging, especially in tuberculosis-endemic regions. Concordant with these study results, in our analysis of 42 peritoneal lesions, there were no significant differences in the RI values of SUVmax, SUVmean, or MTV between the malignant and benign groups, although SUVmax 1 , SUVmax 2 and SUVmean 1 , SUVmean 2 showed a significant difference. Only the RI of TLG showed a significant difference between the two groups. However, TLG 1 showed no significant difference between the two groups, and this was not in agreement with the previous results of TLG 1 analyzed in a total of 51 lesions. When considering these coincident results, the reliability of RI of TLG seems to be low, and further studies are needed. These results that delayed parameters did not show significant differences between the two groups are discordant with our previous study [31] and it might be due to the lesion based analysis in this study. Two peritoneal tuberculosis patients showed eight intraperitoneal lesions among the 19 benign lesions and their FDG activities were markedly high, compared with the other benign lesions. As a result, mean values of several delayed parameters of benign group could be higher than mean value assessed by patient based method. Tuberculosis is typical case of active inflammatory condition as above mentioned.
We performed a visual assessment for 51 total peritoneal lesions and also in 42 lesions for which 2-h delayed 18 F-FDG PET/CT imaging had been acquired. We used a linear-by-linear association for trend test to find associations between each visual parameter and malignancy. In the analysis of both 51 peritoneal lesions and 42 lesions, visual parameters including metabolic intensity, shape, and heterogeneity showed significant associations with malignancy. However, metabolic extent did not show a significant association with malignancy. It might have resulted from the size criteria we used. Because there is no previous study about metabolic size of ovarian malignancy or benign pelvic disease, we scored metabolic extent in the same way as a previous study that evaluated metabolic extent of cervical cancer [19] . A follow-up study on the metabolic size of intraperitoneal lesions will be needed to identify the optimal criteria.
Nevertheless, the total visual score did show a significant association. Furthermore, in the ROC curve analysis, visual score was the most effective parameter to diagnose malignancy compared with other significant diagnostic parameters. Therefore, we considered that visual assessment is a reliable parameter.
Our study has some inherent limitations. First of all, we analyzed each peritoneal lesion independently. However, lesion by lesion analysis could lead to correlation bias among the intraperitoneal lesions from same patient. And also, our data showed nonparametric distribution due to the small number of patients included in this study. These limitations could decrease statistical reliability. So, further study of a larger patient population will be needed. Secondly, because it was a retrospective study, selection bias was introduced. Because all of patients were taken 18 F-FDG PET/CT as a part of stage workup process for ovarian cancer, benign group of this study could not reflect general characteristics of benign pelvic diseases. Thirdly, we could not confirm all intraperitoneal lesions pathologically. We considered all intraperitoneal lesions in patients with malignancy as malignant lesions, in patient with benign disease as benign lesions. However, we retrospectively reviewed the status of malignant patients after chemotherapy, and we identified most of intraperioneal lesions in malignant patients that showed a to the chemotherapy on follow-up abdomen-pelvis CT, pelvic MRI or 18 F-FDG PET/CT. So, it is quite reasonable that intraperitoneal lesions from malignant patients were considered as malignant lesions.
Conclusion
In conclusion, we found that visual assessment was the most significant parameter in differentiating malignancy from benign lesions in ovarian cancer patients, although other semiquantitative parameters including SUVmax 1 , SUVmax 2 , SUVmean 1 , SUVmean 2 , TLG, and RI of TLG were also identified as showing significant diagnostic value. In practice, visual assessment is the simplest and most common method to interpret 18 F-FDG PET/CT imaging and requires no additional time or cost to measure volume-based parameters, and no additional delayed images to measure delayed parameters. Thus, visual assessment has a primary role in detecting malignancy in ovarian cancer patients with assistance from other semi-quantitative parameters.
